文献速递产科母胎医学生殖医学

非整倍体植入前遗传学检测后的产前筛查:是时候评估旧策略了

Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies.
PubMed 文献 · Reprod Biomed Online · 2023-12-04

该回顾性队列研究纳入2013年1月至2022年6月单中心产前随访的20237名孕妇,比较PGT-A筛查后IVF妊娠、未行PGT-A的IVF妊娠与自然妊娠三组。PGT-A组常规联合筛查特异度为91%,因无胎儿非整倍体病例而无法计算敏感度;该组高风险结果中89.1%与高龄(筛查时>35岁)相关。作者认为现行策略在PGT-A妊娠中可产生不必要的检查,需制定更重视超声标志物的新方案。

要点

  • PGT-A后IVF妊娠常规联合筛查特异度为91%,因无胎儿非整倍体病例敏感度无法计算。
  • PGT-A组21、18或13三体高风险结果中89.1%与筛查时高龄(>35岁)相关。
  • 作者认为现行筛查策略在PGT-A妊娠中可产生不必要检查,需更重视超声标志物的新方案。

核心结论

  • 现行21、18、13三体筛查策略在PGT-A后IVF妊娠中可产生不必要的检查。
  • 作者认为需要为这些患者制定新方案,更重视超声标志物。

研究设计与样本

  • 回顾性队列研究,2013年1月至2022年6月在单一三级医疗中心开展。
  • 共20237名在研究中心的产前随访孕妇纳入研究。
  • 分为三组:PGT-A筛查后整倍体胚胎移植的单胎妊娠(n=510)、未行PGT-A的IVF单胎妊娠(n=3291)、自然妊娠单胎妊娠(n=16436)。

主要发现

  • PGT-A后IVF妊娠常规联合筛查特异度为91%。
  • PGT-A后IVF妊娠组无胎儿非整倍体病例,敏感度无法计算。
  • PGT-A后IVF妊娠中21、18或13三体高风险结果有89.1%与筛查时高龄(>35岁)相关。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为现行筛查策略在PGT-A后IVF妊娠中可产生不必要的检查,并认为需要制定更重视超声标志物的新方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: How does first-trimester aneuploidy screening perform in pregnancies achieved through IVF with preimplantation genetic testing for aneuploidy (PGT-A) in a medical setting? DESIGN: This retrospective cohort study was undertaken in a single tertiary care centre between January 2013 and June 2022. In total, 20,237 women had prenatal follow-up at the study centre and were included in the study. The women were divided into three groups: singleton pregnancies conceived through the transfer of a PGT-A-screened euploid embryo (n = 510); singleton pregnancies conceived through IVF without PGT-A (n = 3291); and singleton pregnancies conceived naturally (n = 16,436). RESULTS: The conventional combined screening test for pregnancies conceived through IVF with PGT-A had specificity of 91%; sensitivity could not be calculated as there were no cases of fetal aneuploidy in this group. In 89.1% of pregnancies conceived through IVF with PGT-A with high risk for trisomy 21, 18 or 13, the result was related to advanced maternal age (>35 years at time of screening). CONCLUSIONS: The current screening strategy for trisomies 21, 18 and 13 can generate unnecessary tests in pregnancies achieved through IVF with PGT-A. A new protocol is needed for these patients, with greater weight given to ultrasound markers.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Palacios-Verdú MG, Rodríguez-Melcón A, Rodríguez I, et al. Prenatal screening after preimplantation genetic testing for aneuploidy: time to evaluate old strategies. Reprod Biomed Online. 2023. PMID: 38603981. doi:10.1016/j.rbmo.2023.103761

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。